GeneDx
Mack Nelson is an IT Systems Engineering Manager at GeneDx, responsible for managing IT systems engineering processes and teams since October 2024. Previously, Mack served as the Director of IT at WAEPA, where leadership of a team of IT professionals focused on security, network, infrastructure, and application support, as well as collaboration with C-level executives to modernize systems. Prior experiences include Information Technology Service Delivery Manager at TEKsystems, overseeing engagements for Bloomberg Industry Group, and Office 365 Migration Service Desk Manager at Indigo IT LLC. Early career roles include Desktop Support Technician at SAIC, providing maintenance and technical support for the US Department of Health and Human Services. Mack holds a Bachelor of Fine Arts (B.F.A.) in Theatre Production from Marshall University, where studies emphasized set and costume design, earning Dean's List honors.
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.